Sandra Levy
ARTICLES BY THIS AUTHOR
- 1/10/2021
Kinney’s New York pharmacies to provide COVID-19 vaccines to older patients
All New York Kinney Drugs pharmacies will receive initial doses of the Moderna COVID-19 vaccine to administer only to those age 75 years old and older. - 1/10/2021
Dr. Reddy’s intros generic Uloric
The Uloric brand and generic had a market value of approximately $108 million for the most recent 12 months ended October 2020, according to IQVIA. - 1/7/2021
Schnuck Markets appoints head of fresh
Ted Schnuck, the new vice president of Schnucks' fresh division, also will be part of the company's strategy team. - 1/7/2021
NACDS’ Steve Anderson reflects on events at the U.S. Capitol
NACDS president and CEO Steve Anderson shared his thoughts with staff and members on the horrendous events at the nation's Capitol on Jan. 6. - 1/7/2021
Amneal launches generic Zytiga in new dosage strength
The Food and Drug Administration approved Amneal’s abiraterone acetate tablets in a dosage strength of 500 mg. - 1/7/2021
Sun Pharmaceutical intros generic Concerta
Sun Pharmaceutical's methylphenidate hydrochloride ER tablets are available in four dosage strengths. - 1/6/2021
Lupin gets FDA OK for generic Bactrim
Sulfamethoxazole and trimethoprim oral suspension has a market value of approximately $19 million. - 1/6/2021
Slayback Pharma gets $50 million investment from The Everstone Group
The Everstone Group is investing up to $50 million in Series B funding to expand and accelerate Slayback's pipeline of complex generic and specialty pharmaceutical products. - 1/5/2021
CVS Health names Michelle Peluso chief customer officer
Michelle Peluso, previously senior vice president, digital sales and chief marketing officer at IBM, will join CVS Health as the company's first chief customer officer. - 1/5/2021
Walgreens, CVS Health share LTC facility COVID-19 vaccine progress
CVS Health and Walgreens said they expect to complete the administration of COVID-19 vaccines in skilled long-term care facilities nationwide by Jan. 25.
